SEARCH

SEARCH BY CITATION

References

  • 1
    Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S. Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ. 2004;170(11):16657.
  • 2
    Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis?. J Bone Miner Res. 1992;7(9):100510.
  • 3
    Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS). L'ostéoporose et les fractures chez les personnes de 65 ans et plus: recommandations pour un cadre intégré d'intervention au Québec.: Rapport préparé par Michel Rossignol et collaborateurs. (AÉTMIS 04-1RF). Montréal; Canada: AÉTMIS; p. ix68. 2001.
  • 4
    Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD. Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):186473.
  • 5
    Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess. 2005;9(22):1160.
  • 6
    Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:65766.
  • 7
    Schwartz EN, Steinberg DM. Prescreening tools to determine who needs DXA. Curr Osteoporos Rep. 2006;4:14852.
  • 8
    Durand A, Gagné C, et al., Population-based simulation for public health: generic software infrastructure and its application to osteoporosis. IEEE Trans Syst Man Cybern B Cybern. 2012.
  • 9
    Durand A, Gagné C, Gardner M-A, Rousseau F, Giguère Y. SCHNAPS: a generic population-based simulator for public health purposes. In: Proceedings of the 2010 Summer Simulation Multiconference July 12-14, Ottawa, ON; Canada: (Summer Computer Simulation Conference (SCSC); p. 1829. 2010.
  • 10
    Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177(6):57580.
  • 11
    Cummings SR, Melton LJ 3rd. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:17617.
  • 12
    Goeree R, Blackhouse G, Adachi J. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin. 2006;22:142536.
  • 13
    Melton LJ 3rd, Crowson CS, O'Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int. 1999;9(1):2937.
  • 14
    Tosteson AN, Melton LJ 3rd. Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL; National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19(4):43747.
  • 15
    Institut de la Statistique du Québec (ISQ). Probabilité de décès par âge. Québec: Institut de la statistique du Québec; 2008.
  • 16
    Gagné G, Reinharz D, Laflamme N, Adams PC, Rousseau F. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms. Clin Genet. 2007;71(1):4658.
  • 17
    Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D. Canadian Multicentre Osteoporosis Study Research Group. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int. 2011;22(6):187383.
  • 18
    Giroux S, Elfassihi L, Cardinal G, Laflamme N, Rousseau F. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone. 2007;40(5):1299307.
  • 19
    Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M, Baranci M, Bessant J, Brown JP. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int. 2008;19:7986.
  • 20
    Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004;15(12):10038.
  • 21
    Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009;181(5):26571.
  • 22
    Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, Bell NR, Morrish DW. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med. 2009;169(1):2531.
  • 23
    Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int. 2001;12(4):2718.
  • 24
    National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8 Suppl 4 S780.
  • 25
    Khan SA, de Geus C, Holroyd B, Russell AS. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med. 2001;161(10):130912.
  • 26
    Stevenson M, Lylod JM, Papaioannou D. Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess. 2009 Sep; 13(45): iii–xi, 1134.
  • 27
    Moayyeri A. The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research. Ann Epidemiol. 2008;18(11):82735.
  • 28
    Morin S, Tsang JF, Leslie WD. Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int. 2009;20(3):36370.
  • 29
    Cadarette SM, Jaglal SB, Murray TM. Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry. Osteoporos Int. 1999;10(1):8590.
  • 30
    Cadarette SM, McIsaac WJ, Hawker GA, Jaakkimainen L, Culbert A, Zarifa G, Ola E, Jaglal SB. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004;15(5):3616.
  • 31
    Institut national de santé publique du Québec (INSPQ). Programme Québécois de Dépistage du Cancer du Sein. Tableau de Bord: Indicateurs de Performance du PQDCS, in Québec. Québec:Institut National de Santé Publique du Québec; 2009.
  • 32
    Cranney AB, Coyle D, Hopman WM, Hum V, Power B, Tugwell PS. Prospective evaluation of preferences and quality of life in women with hip fractures. J Rheumatol. 2005;32(12):23939.
  • 33
    Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M, Tenenhouse A, Prior JC, Olszynski WP, Adachi JD. CaMos Study Group. The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2009;20(5):70314.
  • 34
    Cranney A, Coyle D, Pham BA, Tetroe J, Wells G, Jolly E, Tugwell P. The psychometric properties of patient preferences in osteoporosis. J Rheumatol. 2001;28(1):1327.
  • 35
    Régie d'assurance maladie du Québec (RAMQ). Manuel des médecins spécialistes. Québec: Direction des services à la clientèle professionnelle; 2010.
  • 36
    Ministère de la santé et de services sociaux du Québec (MSSS). SIFO Système d'Information Financière et Opérationnelle: méthodologie. Québec: Direction de la gestion de l'information, Gouvernement du Québec; 2007.
  • 37
    Bouee S, Lafuma A, Fagnani F, Meunier PJ, Reginster JY. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int. 2006;26(12):106372.
  • 38
    Ministère de la santé et de services sociaux du Québec (MSSS). Banque de données APR-DRG (All Patient Refined Diagnosis Related Groups). Québec: Ministère de la Santé et des Services Sociaux du Québec; 2007.
  • 39
    Ministère de la santé et de services sociaux du Québec (MSSS). Diem hébergement en soins de longue durée. Québec: Direction de la documentation; 2008.
  • 40
    Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002;167: Suppl 10: S134.
  • 41
    RAMQ. Manuel des pharmaciens. Quebec: Direction des services à la clientèle professionnelle; 2007.
  • 42
    Agence de santé et des services sociaux de la Capitale-Nationale. Programme 0-5-30: une combinaison gagnante. Québec: Agence de santé et des services sociaux de la Capitale-Nationale; 2010.
  • 43
    Rahmani P, Morin S. Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ. 2009;181(11):81520.
  • 44
    Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD. The osteoporosis care gap in Canada. BMC Musculoskelet Disord. 2004;5:11.
  • 45
    Nolin B, Hamel D. L'activité physique au Québec de 1995 à 2005: gains pour tous…ou presque. In: Fahmy M (sous la direction de): L'État du Québec 2009: tout ce qu'il faut savoir sur le Québec d'aujourd'hui. Montréal; Fides: p. 2717. 2008.
  • 46
    Brown JP, Fortier M, Frame H, Lalonde A, Papaioannou A, Senikas V, Yuen CK, Osteoporosis Guidelines Committee. Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can. 2006 Feb; 28 (2 Suppl 1): S95112.
  • 47
    Majumdar SR, Johnson JA, Lier DA, Russell AS, Hanley DA, Blitz S, Steiner IP, Maksymowych WP, Morrish DW, Holroyd BR, Rowe BH. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int. 2007;18:26170.
  • 48
    Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes 3rd ed. Oxford: Oxford University Press; 379 pp. 2005.
  • 49
    Sendi PP, Briggs AH. Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health Econ. 2001;10(7):67580.
  • 50
    Menon D, Stafinski T. Health technology assessment in Canada: 20 years strong?. Value Health. 2009 Jun;12 Suppl 2 S149.
  • 51
    National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
  • 52
    Mueller D, Gandjour A. Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women. Appl Health Econ Health Policy. 2008;6(2–3):11335.
  • 53
    Mueller D, Gandjour A. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Value Health. 2009;12(8):110617.
  • 54
    Soares M, Dumville JC. Critical appraisal of cost-effectiveness and cost-utility studies in health care. Evid Based Nurs. 2008;11(4):99102.
  • 55
    Soto J. Health Economic evaluations using decision analytic modeling. Principles and practices: utilization of a checklist to their development and appraisal. Int J Technol Assess Health Care. 2002;18:94111.
  • 56
    Conner M, Norman P. Predicting health behaviour: research and practice with social cognition models. Maidenhead, UK: Open University Press; 2005.
  • 57
    National Institute for Health and Clinical Excellence (NICE). NICE public health guidance 6. Behaviour change at population, community and individual levels. London: NICE; 2007.
  • 58
    Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010 Jun;21 Suppl 2 S40713.